Related Experiment Videos
Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants
F von Weizsäcker1, S Wieland, J Köck
1Department of Medicine II, University Hospital, Freiburg, Germany.
Hepatology (Baltimore, Md.)
|August 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Trends in hepatitis C-related mortality in Switzerland.
Journal of viral hepatitis·2017
Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach.
Journal of viral hepatitis·2016
Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding.
Alimentary pharmacology & therapeutics·2015
Hepatitis C virus infection and kidney transplantation in 2014: what's new?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.
Hepatology (Baltimore, Md.)·2026
Drug-Induced Liver Injury (DILI) in clinical trials: Views and practical updates from DILI specialists at FDA.
Hepatology (Baltimore, Md.)·2026
Targeted AAV gene therapy for neuroblastoma via direct capsid-antibody coupling.
EMBO molecular medicine·2026
Exogenous Melatonin Alleviates Liver Injury via Regulating Hepatocellular PI3K/AKT Pathway and Inhibiting NLRP3 Activation.
European journal of pharmacology·2026
A therapeutic atlas of monogenic inflammatory bowel disease.
Journal of Crohn's & colitis·2026
German Delphi consensus: COMT inhibitors in the management of wearing-off fluctuations in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996)·2026